{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:59:29Z","timestamp":1792425569347,"version":"4.5.0"},"reference-count":128,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Diabetic kidney disease (DKD), as one of the most serious microvascular complications of diabetes, is the main cause of end-stage renal disease in the world. Lipid peroxidation plays a crucial role in the development and progression of DKD. Under conditions of high glucose and insulin resistance, renal lipid metabolism disorders result in abnormal accumulation of polyunsaturated fatty acids (PUFAs), which undergo lipid peroxidation via free radical chain reactions to generate reactive aldehydes. These substances not only directly damage the cell structure but can also be used as signaling molecules that activate pathways related to inflammation, fibrosis, and ferroptosis, eventually leading to glomerular sclerosis and tubulointerstitial fibrosis. Natural products have shown considerable application prospects in the treatment of DKD due to their multi-functional properties, including anti-inflammatory, antioxidant, and lipid-metabolism-regulating effects. To elucidate this, we conducted a systematic review of the literature available in electronic databases (including PubMed, Web of Science, and Scopus, and Google Scholar) from January 2000 to May 2025. This study further discusses the therapeutic effect and mechanism of natural products targeting lipid peroxidation in DKD. The results indicate that natural products are promising anti-lipid peroxidation drugs. Further clinical trials will be necessary to verify the safety and effectiveness of these natural compounds in clinical applications, thereby laying the foundation for developing novel treatment strategies for DKD.<\/jats:p>","DOI":"10.3390\/ijms26199764","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T15:48:30Z","timestamp":1759852110000},"page":"9764","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Lipid Peroxidation in Diabetic Kidney Disease: Mechanism and Natural Solution"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7774-8232","authenticated-orcid":false,"given":"Yuxin","family":"Dong","sequence":"first","affiliation":[{"name":"College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun 130000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1015-2127","authenticated-orcid":false,"given":"Yanqing","family":"Tong","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun 130000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group (2022). KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int., 102, S1\u2013S127.","DOI":"10.1016\/j.kint.2022.06.008"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41581-024-00827-z","article-title":"Combination therapy for kidney disease in people with diabetes mellitus","volume":"20","author":"Bjornstad","year":"2024","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/17460441.2021.1832077","article-title":"Recent advances in drug discovery for diabetic kidney disease","volume":"16","author":"Danta","year":"2021","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Njeim, R., Alkhansa, S., and Fornoni, A. (2023). Unraveling the crosstalk between lipids and NADPH oxidases in diabetic kidney disease. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15051360"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00018-023-05078-y","article-title":"Mitochondrial oxidative damage reprograms lipid metabolism of renal tubular epithelial cells in the diabetic kidney","volume":"81","author":"Hou","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/dmrr.493","article-title":"Diabetes: Insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storage","volume":"21","author":"Raz","year":"2005","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Gai, Z., Wang, T., Visentin, M., Kullak-Ublick, G.A., Fu, X., and Wang, Z. (2019). Lipid accumulation and chronic kidney disease. Nutrients, 11.","DOI":"10.3390\/nu11040722"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Zhou, K., Zi, X., Song, J., Zhao, Q., Liu, J., Bao, H., and Li, L. (2022). Molecular mechanistic pathways targeted by natural compounds in the prevention and treatment of diabetic kidney disease. Molecules, 27.","DOI":"10.3390\/molecules27196221"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Zhao, X., An, X., Yang, C., Sun, W., Ji, H., and Lian, F. (2023). The crucial role and mechanism of insulin resistance in metabolic disease. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1149239"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","article-title":"Mechanisms of insulin action and insulin resistance","volume":"98","author":"Petersen","year":"2018","journal-title":"Physiol. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41392-024-01951-9","article-title":"Type 2 diabetes mellitus in adults: Pathogenesis, prevention and therapy","volume":"9","author":"Lu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Pucha\u0142owicz, K., and Ra\u0107, M.E. (2020). The multifunctionality of CD36 in diabetes mellitus and its complications-update in pathogenesis, treatment and monitoring. Cells, 9.","DOI":"10.3390\/cells9081877"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000448357","article-title":"Fatty acid oxidation and its relation with insulin resistance and associated disorders","volume":"68","author":"Lopaschuk","year":"2016","journal-title":"Ann. Nutr. Metab."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"bqz046","DOI":"10.1210\/endocr\/bqz046","article-title":"CPT1A-mediated fat oxidation, mechanisms, and therapeutic potential","volume":"161","author":"Schlaepfer","year":"2020","journal-title":"Endocrinology"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Jang, H.S., Noh, M.R., Kim, J., and Padanilam, B.J. (2020). Defective mitochondrial fatty acid oxidation and lipotoxicity in kidney diseases. Front. Med., 7.","DOI":"10.3389\/fmed.2020.00065"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12986-018-0241-7","article-title":"Associations between fatty acid oxidation, hepatic mitochondrial function, and plasma acylcarnitine levels in mice","volume":"15","author":"Lindquist","year":"2018","journal-title":"Nutr. Metab."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1194\/jlr.P040501","article-title":"Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy","volume":"55","author":"Scherzer","year":"2014","journal-title":"J. Lipid Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e140695","DOI":"10.1172\/JCI140695","article-title":"Renal tubule CPT1A overexpression protects from kidney fibrosis by restoring mitochondrial homeostasis","volume":"131","author":"Miguel","year":"2021","journal-title":"J. Clin. Invest."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0952-3278(02)00264-8","article-title":"Essential fatty acid synthesis and its regulation in mammals","volume":"68","author":"Nakamura","year":"2003","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Li, L., Long, J., Mise, K., Poungavrin, N., Lorenzi, P.L., Mahmud, I., Tan, L., Saha, P.K., Kanwar, Y.S., and Chang, B.H. (2023). The transcription factor ChREBP links mitochondrial lipidomes to mitochondrial morphology and progression of diabetic kidney disease. J. Biol. Chem., 299.","DOI":"10.1016\/j.jbc.2023.105185"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cmet.2023.11.017","article-title":"Mitochondrial fatty acid synthesis is an emergent central regulator of mammalian oxidative metabolism","volume":"36","author":"Wedan","year":"2024","journal-title":"Cell Metab."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.yexcr.2015.06.006","article-title":"Co-regulation of SREBP-1 and mTOR ameliorates lipid accumulation in kidney of diabetic mice","volume":"336","author":"Wang","year":"2015","journal-title":"Exp. Cell Res."},{"key":"ref_23","first-page":"1","article-title":"FTZ alleviates lipid deposition in diabetic kidney disease by AMPK\/ACC\/SREBP signaling pathway","volume":"62","author":"Tao","year":"2025","journal-title":"Acta Diabetol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41581-023-00741-w","article-title":"Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease","volume":"19","author":"Mitrofanova","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s11892-019-1263-x","article-title":"Crosstalk between lipids and mitochondria in diabetic kidney disease","volume":"19","author":"Ducasa","year":"2019","journal-title":"Curr. Diab. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.plipres.2013.12.001","article-title":"Regulation of energy metabolism by long-chain fatty acids","volume":"53","author":"Nakamura","year":"2014","journal-title":"Prog. Lipid Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nrneph.2017.107","article-title":"Mitochondrial energetics in the kidney","volume":"13","author":"Bhargava","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"155195","DOI":"10.1016\/j.metabol.2022.155195","article-title":"Mitochondrial dysfunction in diabetic tubulopathy","volume":"131","author":"Yao","year":"2022","journal-title":"Metabolism"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Ito, M., Gurumani, M.Z., Merscher, S., and Fornoni, A. (2022). Glucose- and non-glucose-induced mitochondrial dysfunction in diabetic kidney disease. Biomolecules, 12.","DOI":"10.3390\/biom12030351"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Braga, P.C., Alves, M.G., Rodrigues, A.S., and Oliveira, P.F. (2022). Mitochondrial pathophysiology on chronic kidney disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031776"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Efiong, E.E., Bazireh, H., Fuchs, M., Amadi, P.U., Effa, E., Sharma, S., and Schmaderer, C. (2024). Crosstalk of hyperglycaemia and cellular mechanisms in the pathogenesis of diabetic kidney disease. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252010882"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ejphar.2018.06.001","article-title":"AGE-RAGE axis blockade in diabetic nephropathy: Current status and future directions","volume":"833","author":"Sanajou","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Pathomthongtaweechai, N., and Chutipongtanate, S. (2020). AGE\/RAGE signaling-mediated endoplasmic reticulum stress and future prospects in non-coding RNA therapeutics for diabetic nephropathy. Biomed. Pharmacother., 131.","DOI":"10.1016\/j.biopha.2020.110655"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1681\/ASN.2007101109","article-title":"RAGE mediates podocyte injury in adriamycin-induced glomerulosclerosis","volume":"19","author":"Guo","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/ki.2015.331","article-title":"Kallistatin protects against diabetic nephropathy in db\/db mice by suppressing AGE-RAGE-induced oxidative stress","volume":"89","author":"Yiu","year":"2016","journal-title":"Kidney Int."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"104633","DOI":"10.1016\/j.phrs.2020.104633","article-title":"Oral administration of spa-derived green alga improves insulin resistance in overweight subjects: Mechanistic insights from fructose-fed rats","volume":"152","author":"Kaseda","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2337\/db08-1536","article-title":"Mechanisms of podocyte injury in diabetes: Role of cytochrome P450 and NADPH oxidases","volume":"58","author":"Eid","year":"2009","journal-title":"Diabetes"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"14599","DOI":"10.1021\/acs.jmedchem.2c01089","article-title":"Discovery of novel pyrazolylpyridine derivatives for 20-hydroxyeicosatetraenoic acid synthase inhibitors with selective CYP4A11\/4F2 inhibition","volume":"65","author":"Kawamura","year":"2022","journal-title":"J. Med. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.bbamcr.2018.02.010","article-title":"Nrf2-Keap1 signaling in oxidative and reductive stress","volume":"1865","author":"Bellezza","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Liu, Y., Uruno, A., Saito, R., Matsukawa, N., Hishinuma, E., Saigusa, D., Liu, H., and Yamamoto, M. (2022). Nrf2 deficiency deteriorates diabetic kidney disease in Akita model mice. Redox Biol., 58.","DOI":"10.1016\/j.redox.2022.102525"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Hashemi, M., Zandieh, M.A., Ziaolhagh, S., Mojtabavi, S., Sadi, F.H., Koohpar, Z.K., Ghanbarirad, M., Haghighatfard, A., Behroozaghdam, M., and Khorrami, R. (2023). Nrf2 signaling in diabetic nephropathy, cardiomyopathy and neuropathy: Therapeutic targeting, challenges and future prospective. Biochim. Biophys. Acta Mol. Basis Dis., 1869.","DOI":"10.1016\/j.bbadis.2023.166714"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jsps.2015.03.013","article-title":"Diabetes mellitus and oxidative stress-A concise review","volume":"24","author":"Asmat","year":"2016","journal-title":"Saudi Pharm. J."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1385\/CBB:43:2:289","article-title":"The role of oxidative stress in diabetic complications","volume":"43","author":"Niedowicz","year":"2005","journal-title":"Cell Biochem. Biophys."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.1021\/cr200084z","article-title":"Free radical lipid peroxidation: Mechanisms and analysis","volume":"111","author":"Yin","year":"2011","journal-title":"Chem. Rev."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"5080843","DOI":"10.1155\/2019\/5080843","article-title":"Reactive oxygen species-induced lipid peroxidation in apoptosis, autophagy, and ferroptosis","volume":"2019","author":"Su","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"360438","DOI":"10.1155\/2014\/360438","article-title":"Lipid peroxidation: Production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal","volume":"2014","author":"Ayala","year":"2014","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/1476-511X-10-201","article-title":"Protein conjugated with aldehydes derived from lipid peroxidation as an independent parameter of the carbonyl stress in the kidney damage","volume":"10","year":"2011","journal-title":"Lipids Health Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.2174\/1389557521666210105110538","article-title":"Chemistry and reactivity of 4-hydroxy-2-nonenal (HNE) in model biological systems","volume":"21","author":"Vazdar","year":"2021","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Epizzimenti, S., Ciamporcero, E.S., Edaga, M., Epettazzoni, P., Earcaro, A., Ecetrangolo, G., Eminelli, R., Edianzani, C., Elepore, A., and Egentile, F. (2013). Interaction of aldehydes derived from lipid peroxidation and membrane proteins. Front. Physiol., 4.","DOI":"10.3389\/fphys.2013.00242"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.3390\/biom5042247","article-title":"4-Hydroxy-nonenal-a bioactive lipid peroxidation product","volume":"5","author":"Schaur","year":"2015","journal-title":"Biomolecules"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Soulage, C.O., Pelletier, C.C., Florens, N., Lemoine, S., Dubourg, L., Juillard, L., and Guebre-Egziabher, F. (2020). Two toxic lipid aldehydes, 4-hydroxy-2-hexenal (4-HHE) and 4-hydroxy-2-nonenal (4-HNE), accumulate in patients with chronic kidney disease. Toxins, 12.","DOI":"10.3390\/toxins12090567"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Mu, F., Luo, P., Zhu, Y., Nie, P., Li, B., and Bai, X. (2025). Iron metabolism and ferroptosis in diabetic kidney disease. Cell Biochem. Funct., 43.","DOI":"10.1002\/cbf.70067"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Barnabei, L., Laplantine, E., Mbongo, W., Rieux-Laucat, F., and Weil, R. (2021). NF-\u03baB: At the borders of autoimmunity and inflammation. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.716469"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"White, S., Lin, L., and Hu, K. (2020). NF-\u03baB and tPA signaling in kidney and other diseases. Cells, 9.","DOI":"10.3390\/cells9061348"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0098-2997(03)00018-9","article-title":"4-hydroxynonenal triggers multistep signal transduction cascades for suppression of cellular functions","volume":"24","author":"Nakashima","year":"2003","journal-title":"Mol. Asp. Med."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Ioannidis, M., Tjepkema, J., Uitbeijerse, M.R.P., and van den Bogaart, G. (2025). Immunomodulatory effects of 4-hydroxynonenal. Redox Biol., 85.","DOI":"10.1016\/j.redox.2025.103719"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.redox.2012.12.005","article-title":"Redox-derived damage-associated molecular patterns: Ligand function of lipid peroxidation adducts","volume":"1","author":"Uchida","year":"2013","journal-title":"Redox Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41581-019-0234-4","article-title":"Innate immunity in diabetic kidney disease","volume":"16","author":"Tang","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev-immunol-081022-021207","article-title":"Structural mechanisms of NLRP3 inflammasome assembly and activation","volume":"41","author":"Fu","year":"2023","journal-title":"Annu. Rev. Immunol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"122813","DOI":"10.1016\/j.lfs.2024.122813","article-title":"NLRP3 inflammasome: A central player in renal pathologies and nephropathy","volume":"351","author":"Henedak","year":"2024","journal-title":"Life Sci."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Liu, P., Zhang, Z., and Li, Y. (2021). Relevance of the pyroptosis-related inflammasome pathway in the pathogenesis of diabetic kidney disease. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.603416"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Foresto-Neto, O., Albino, A.H., Arias, S.C.A., Faustino, V.D., Zambom, F.F.F., Cenedeze, M.A., Elias, R.M., Malheiros, D.M.A.C., Camara, N.O.S., and Fujihara, C.K. (2020). NF-\u03baB system is chronically activated and promotes glomerular injury in experimental type 1 diabetic kidney disease. Front. Physiol., 11.","DOI":"10.3389\/fphys.2020.00084"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00018-024-05433-7","article-title":"Cytosolic Hmgb1 accumulation in mesangial cells aggravates diabetic kidney disease progression via NF\u03baB signaling pathway","volume":"81","author":"Wu","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Sharma, S., Sharma, P., Bailey, T., Bhattarai, S., Subedi, U., Miller, C., Ara, H., Kidambi, S., Sun, H., and Panchatcharam, M. (2022). Electrophilic aldehyde 4-hydroxy-2-nonenal mediated signaling and mitochondrial dysfunction. Biomolecules, 12.","DOI":"10.3390\/biom12111555"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/ars.2017.7115","article-title":"GPx4, lipid oeroxidation, and cell death: Discoveries, rediscoveries, and open issues","volume":"29","author":"Maiorino","year":"2018","journal-title":"Antioxid. Redox Signal"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.freeradbiomed.2023.08.014","article-title":"Lipid peroxidation-derived modification and its effect on the activity of glutathione peroxidase 1","volume":"208","author":"Lee","year":"2023","journal-title":"Free Radic. Biol. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0891-5849(98)00335-9","article-title":"4-Hydroxynonenal inhibits glutathione peroxidase: Protection by glutathione","volume":"26","author":"Romero","year":"1999","journal-title":"Free Radic. Biol. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-981-13-9589-5_2","article-title":"Cellular iron metabolism and regulation","volume":"1173","author":"Gao","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Zhong, S., Wang, N., and Zhang, C. (2024). Podocyte death in diabetic kidney disease: Potential molecular mechanisms and therapeutic targets. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25169035"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.7150\/ijbs.81892","article-title":"Emerging role of ferroptosis in diabetic kidney disease: Molecular mechanisms and therapeutic opportunities","volume":"19","author":"Wang","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s10534-025-00706-5","article-title":"Overexpression of GPX4 in diabetic rat kidney alleviates renal injury induced by ferroptosis","volume":"38","author":"Wu","year":"2025","journal-title":"Biometals"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Khamis, M.M., Moselhy, S.S., and Rihan, S. (2025). Role of trans-resveratrol in ameliorating biochemical and molecular alterations in obese rats induced by a high fructose\/fat diet. Sci. Rep., 15.","DOI":"10.1038\/s41598-025-91027-7"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Sikur, N., B\u00f6r\u00f6czky, C., Pasztern\u00e1k, A., Gy\u00f6ngy\u00f6ssy, R., Sz\u00f6k\u0151, \u00c9., Varga, K., and T\u00e1bi, T. (2024). Resveratrol and its derivatives diminish lipid accumulation in adipocytes in vitro-mechanism of action and structure-activity relationship. Nutrients, 16.","DOI":"10.3390\/nu16223869"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"174776","DOI":"10.1016\/j.ejphar.2022.174776","article-title":"Resveratrol ameliorates diabetic kidney injury by reducing lipotoxicity and modulates expression of components of the junctional adhesion molecule-like\/sirtuin 1 lipid metabolism pathway","volume":"918","author":"Gu","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s00125-012-2747-2","article-title":"Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1\u03b1 axis in db\/db mice","volume":"56","author":"Kim","year":"2013","journal-title":"Diabetologia"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.taap.2017.11.025","article-title":"Trans-resveratrol mitigates type 1 diabetes-induced oxidative DNA damage and accumulation of advanced glycation end products in glomeruli and tubules of rat kidneys","volume":"339","author":"Kilarkaje","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2174\/1871527311312040007","article-title":"Curcumin, an active constiuent of the ancient medicinal herb Curcuma longa L.: Some uses and the establishment and biological basis of medical efficacy","volume":"12","author":"Witkin","year":"2013","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3349\/ymj.2016.57.3.664","article-title":"Protective effects of curcumin on renal oxidative stress and lipid metabolism in a rat model of type 2 diabetic nephropathy","volume":"57","author":"Kim","year":"2016","journal-title":"Yonsei Med. J."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Allemailem, K.S., Almatroudi, A., Alharbi, H.O.A., AlSuhaymi, N., Alsugoor, M.H., Aldakheel, F.M., Khan, A.A., and Rahmani, A.H. (2024). Apigenin: A bioflavonoid with a promising role in disease prevention and treatment. Biomedicines, 12.","DOI":"10.3390\/biomedicines12061353"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1124\/jpet.120.000162","article-title":"Apigenin ameliorates insulin resistance and lipid accumulation by endoplasmic reticulum stress and SREBP-1c\/SREBP-2 pathway in palmitate-induced HepG2 cells and high-fat diet-fed mice","volume":"377","author":"Wu","year":"2021","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"24470","DOI":"10.1039\/C8RA04459G","article-title":"Apigenin ameliorates vascular injury in rats with high fructose-induced metabolic disturbance by inhibiting PI3K\/AKT\/GLUT1","volume":"8","author":"Chen","year":"2018","journal-title":"RSC Adv."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1093\/jn\/133.5.1238","article-title":"Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells","volume":"133","author":"Mezei","year":"2003","journal-title":"J. Nutr."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Misiakiewicz-Has, K., Maciejewska-Markiewicz, D., Szypulska-Koziarska, D., Kolasa, A., and Wiszniewska, B. (2024). The influence of soy isoflavones and soy isoflavones with inulin on kidney morphology, fatty acids, and associated parameters in rats with and without induced diabetes type 2. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25105418"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Danielewski, M., Matuszewska, A., Szel\u0105g, A., and Soza\u0144ski, T. (2021). The impact of anthocyanins and iridoids on transcription factors crucial for lipid and cholesterol homeostasis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22116074"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Herrera-Balandrano, D.D., Chai, Z., Hutabarat, R.P., Beta, T., Feng, J., Ma, K., Li, D., and Huang, W. (2021). Hypoglycemic and hypolipidemic effects of blueberry anthocyanins by AMPK activation: In vitro and in vivo studies. Redox Biol., 46.","DOI":"10.1016\/j.redox.2021.102100"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejphar.2014.09.014","article-title":"Renoprotective effect of myricetin restrains dyslipidemia and renal mesangial cell proliferation by the suppression of sterol regulatory element binding proteins in an experimental model of diabetic nephropathy","volume":"743","author":"Kandasamy","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ptr.5256","article-title":"Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin: An updated review of their molecular mechanisms and experimental models","volume":"29","author":"Parhiz","year":"2015","journal-title":"Phytother. Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.biopha.2019.01.030","article-title":"Hesperetin ameliorates diabetic nephropathy in rats by activating Nrf2\/ARE\/glyoxalase 1 pathway","volume":"111","author":"Chen","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"34342","DOI":"10.1021\/acsomega.5c02026","article-title":"Hesperetin and isoliquiritigenin attenuate the progression of diabetic nephropathy via inhibition of NF-\u03baB\/NLRP3 pathways in type 2 diabetic rats","volume":"10","author":"Meenu","year":"2025","journal-title":"ACS Omega"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Mu\u00f1oz-Reyes, D., Morales, A.I., and Prieto, M. (2021). Transit and metabolic pathways of quercetin in tubular cells: Involvement of its antioxidant properties in the kidney. Antioxidants, 10.","DOI":"10.3390\/antiox10060909"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1142\/S0192415X23500465","article-title":"Quercetin ameliorates diabetic kidney injury by inhibiting ferroptosis via activating Nrf2\/HO-1 signaling pathway","volume":"51","author":"Feng","year":"2023","journal-title":"Am. J. Chin. Med."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Rahmani, A.H., Alsahli, M.A., Khan, A.A., and Almatroodi, S.A. (2023). Quercetin, a plant flavonol attenuates diabetic complications, renal tissue damage, renal oxidative stress and inflammation in streptozotocin-induced diabetic rats. Metabolites, 13.","DOI":"10.3390\/metabo13010130"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.freeradbiomed.2023.03.022","article-title":"Astragaloside IV attenuates podocyte apoptosis through ameliorating mitochondrial dysfunction by up-regulated Nrf2-ARE\/TFAM signaling in diabetic kidney disease","volume":"203","author":"Shen","year":"2023","journal-title":"Free Radic. Biol. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.pharep.2018.12.008","article-title":"Astragaloside IV inhibits palmitate-mediated oxidative stress and fibrosis in human glomerular mesangial cells via downregulation of CD36 expression","volume":"71","author":"Su","year":"2019","journal-title":"Pharmacol. Rep."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"14963","DOI":"10.1021\/acs.jmedchem.3c01548","article-title":"Targeting NOX2 with bivalent small-molecule p47phox-p22phox inhibitors","volume":"66","author":"Zang","year":"2023","journal-title":"J. Med. Chem."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3892\/ijmm.2021.4996","article-title":"Astragaloside IV ameliorates diabetic nephropathy in db\/db mice by inhibiting NLRP3 inflammasome-mediated inflammation","volume":"48","author":"Feng","year":"2021","journal-title":"Int. J. Mol. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"3571614","DOI":"10.1155\/2016\/3571614","article-title":"Sinapic acid and its derivatives as medicine in oxidative stress-induced diseases and aging","volume":"2016","author":"Chen","year":"2016","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Alaofi, A.L. (2020). Sinapic acid ameliorates the progression of streptozotocin (STZ)-induced diabetic nephropathy in rats via NRF2\/HO-1 mediated pathways. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.01119"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Wang, K., Liang, C., Cao, W., Luo, G., Zhong, S., Zeng, Z., Dai, L., and Song, J.L. (2022). Dietary sinapic acid attenuated high-fat diet-induced lipid metabolism and oxidative stress in male Syrian hamsters. J. Food Biochem., 46.","DOI":"10.1111\/jfbc.14203"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.intimp.2017.11.021","article-title":"Chlorogenic acid prevents diabetic nephropathy by inhibiting oxidative stress and inflammation through modulation of the Nrf2\/HO-1 and NF-\u0138B pathways","volume":"54","author":"Bao","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Bao, L., Gong, Y., Xu, W., Dao, J., Rao, J., and Yang, H. (2025). Chlorogenic acid inhibits NLRP3 inflammasome activation through Nrf2 activation in diabetic nephropathy. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0316615"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Gong, P., Wang, P., Pi, S., Guo, Y., Pei, S., Yang, W., Chang, X., Wang, L., and Chen, F. (2021). Proanthocyanidins protect against cadmium-induced diabetic nephropathy through p38 MAPK and Keap1\/Nrf2 signaling pathways. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.801048"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1021\/jf073065v","article-title":"Cinnamon bark proanthocyanidins as reactive carbonyl scavengers to prevent the formation of advanced glycation endproducts","volume":"56","author":"Peng","year":"2008","journal-title":"J. Agric. Food Chem."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Dusabimana, T., Park, E.J., Je, J., Jeong, K., Yun, S.P., Kim, H.J., Kim, H., and Park, S.W. (2021). Geniposide improves diabetic nephropathy by enhancing ULK1-mediated autophagy and reducing oxidative stress through AMPK activation. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22041651"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"173449","DOI":"10.1016\/j.ejphar.2020.173449","article-title":"Geniposide alleviates diabetic nephropathy of mice through AMPK\/SIRT1\/NF-\u03baB pathway","volume":"886","author":"Li","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"30930","DOI":"10.1021\/acsomega.2c02796","article-title":"Lycopene effects on metabolic syndrome and kidney injury in rats fed a high-fat diet: An experimental study","volume":"7","author":"Albrahim","year":"2022","journal-title":"ACS Omega"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.2147\/DMSO.S265944","article-title":"Lycopene improves the metformin effects on glycemic control and decreases biomarkers of glycoxidative stress in diabetic rats","volume":"13","author":"Figueiredo","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.phymed.2018.12.045","article-title":"Coumarin glycosides from Hydrangea paniculata slow down the progression of diabetic nephropathy by targeting Nrf2 anti-oxidation and smad2\/3-mediated profibrosis","volume":"57","author":"Sen","year":"2019","journal-title":"Phytomedicine"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.freeradbiomed.2025.08.019","article-title":"Novel coumarin derivative SZC-6 as an allosteric activator of SIRT3 alleviates diabetic kidney disease via the SIRT3-Foxo3a signaling axis","volume":"240","author":"Liu","year":"2025","journal-title":"Free Radic. Biol. Med."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"119197","DOI":"10.1016\/j.lfs.2021.119197","article-title":"Silymarin nanoliposomes attenuate renal injury on diabetic nephropathy rats via co-suppressing TGF-\u03b2\/Smad and JAK2\/STAT3\/SOCS1 pathway","volume":"271","author":"Chen","year":"2021","journal-title":"Life Sci."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Jin, D., Kang, X., Zhou, R., Sun, Y., Lian, F., and Tong, X. (2021). Signaling pathways involved in diabetic renal fibrosis. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.696542"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3109\/0886022X.2010.486488","article-title":"Silymarin and milk thistle extract may prevent the progression of diabetic nephropathy in streptozotocin-induced diabetic rats","volume":"32","author":"Vessal","year":"2010","journal-title":"Ren. Fail."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1681\/ASN.2019101032","article-title":"Phosphorylation of ACTN4 leads to podocyte vulnerability and proteinuric glomerulosclerosis","volume":"31","author":"Feng","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41581-019-0135-6","article-title":"Epigenetics and epigenomics in diabetic kidney disease and metabolic memory","volume":"15","author":"Kato","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"15593258221105704","DOI":"10.1177\/15593258221105704","article-title":"Epigallocatechin gallate induces the demethylation of actinin alpha 4 to inhibit diabetic nephropathy renal fibrosis via the NF-KB signaling pathway in vitro","volume":"20","author":"He","year":"2022","journal-title":"Dose Response"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"10800","DOI":"10.1002\/fsn3.4617","article-title":"Epigallocatechin-3-gallate ameliorates diabetic kidney disease by inhibiting the TXNIP\/NLRP3\/IL-1\u03b2 signaling pathway","volume":"12","author":"Wang","year":"2024","journal-title":"Food Sci. Nutr."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Skorokhod, O., Barrera, V., Mandili, G., Costanza, F., Valente, E., Ulliers, D., and Schwarzer, E. (2021). Malaria pigment hemozoin impairs GM-CSF receptor expression and function by 4-hydroxynonenal. Antioxidants, 10.","DOI":"10.3390\/antiox10081259"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"101523","DOI":"10.1016\/j.smim.2021.101523","article-title":"Targeting GM-CSF in inflammatory and autoimmune disorders","volume":"54","author":"Achuthan","year":"2021","journal-title":"Semin. Immunol."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Liu, Y., Wang, W., Zhang, J., Gao, S., Xu, T., and Yin, Y. (2023). JAK\/STAT signaling in diabetic kidney disease. Front. Cell Dev. Biol., 11.","DOI":"10.3389\/fcell.2023.1233259"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"11188","DOI":"10.1080\/21655979.2021.2006978","article-title":"Isoliquiritigenin attenuates acute renal injury through suppressing oxidative stress, fibrosis and JAK2\/STAT3 pathway in streptozotocin-induced diabetic rats","volume":"12","author":"Sun","year":"2021","journal-title":"Bioengineered"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"529","DOI":"10.4062\/biomolther.2024.209","article-title":"Andrographolide as a multi-target therapeutic agent in diabetic nephropathy: Insights into STAT3\/PI3K\/Akt pathway modulation","volume":"33","author":"Yin","year":"2025","journal-title":"Biomol. Ther."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.mce.2016.06.029","article-title":"Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt\/NF-\u03baB pathway","volume":"437","author":"Ji","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Ma, X., Chen, Z., Wang, L., Wang, G., Wang, Z., Dong, X., Wen, B., and Zhang, Z. (2018). The pathogenesis of diabetes mellitus by oxidative stress and inflammation: Its inhibition by berberine. Front. Pharmacol., 9.","DOI":"10.3389\/fphar.2018.00782"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1007\/s11655-024-3666-z","article-title":"Berberine inhibits ferroptosis and stabilizes atherosclerotic plaque through NRF2\/SLC7A11\/GPX4 pathway","volume":"30","author":"Wang","year":"2024","journal-title":"Chin. J. Integr. Med."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Chen, J., Ou, Z., Gao, T., Yang, Y., Shu, A., Xu, H., Chen, Y., and Lv, Z. (2022). Ginkgolide B alleviates oxidative stress and ferroptosis by inhibiting GPX4 ubiquitination to improve diabetic nephropathy. Biomed. Pharmacother., 156.","DOI":"10.1016\/j.biopha.2022.113953"},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Liu, Y., Wang, F., Xu, H., Wang, H., Lu, M., and Cheng, L. (2025). Ginkgolide B attenuates hyperlipidemia by restoring sphingolipid homeostasis and activating PPAR\u03b1 and Nrf2 pathways. Sci. Rep., 15.","DOI":"10.1038\/s41598-025-14626-4"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"116667","DOI":"10.1016\/j.jep.2023.116667","article-title":"Tanshinone IIA mediates protection from diabetes kidney disease by inhibiting oxidative stress induced pyroptosis","volume":"316","author":"Wu","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/jdi.14206","article-title":"Tanshinone\u2009IIA suppresses ferroptosis to attenuate renal podocyte injury in diabetic nephropathy through the embryonic lethal abnormal visual-like protein\u20091 and acyl-coenzyme\u2009A synthetase long-chain family member\u20094 signaling pathway","volume":"15","author":"Zhu","year":"2024","journal-title":"J. Diabetes Investig."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/19\/9764\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:50:10Z","timestamp":1760035810000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/19\/9764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":128,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["ijms26199764"],"URL":"https:\/\/doi.org\/10.3390\/ijms26199764","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,7]]}}}